ArticleBlood advances2018
A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells.
Yelena Kovtun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
95 papers cite itlatest 60 shown
this paperpooled ittrialcites it